about
S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast CancerEvaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer.Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trialIntratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer.The effect of oncologists' exercise recommendations on the level of exercise and quality of life in survivors of breast and colorectal cancer: A randomized controlled trialEvaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.Resting heart rate as a prognostic factor for mortality in patients with breast cancer.Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery?A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy.Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.Dermatofibrosarcoma protuberans arising on the skin of the breast.Relationship between resting heart rate and metabolic risk factors in breast cancer patientsTramadol use is associated with enhanced postoperative outcomes in breast cancer patients: a retrospective clinical study with in vitro confirmationPrevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VIRetrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohortValidating breast-cancer risk prediction models in the Korean Cancer Prevention Study-II Biobank
P50
Q33643492-AC6DFD93-6879-4425-8790-B21AF6559193Q35920570-8B847765-91DE-4431-9D85-A07C92733B51Q36145737-EF014976-C3A1-416A-BF34-D8A7373884DFQ36295344-C156FE29-FE1D-4AAF-B02D-8F14FB996B03Q36822535-11262A51-D69E-494F-86A9-D941841B8933Q37259483-91FA25B1-0355-43DD-8093-3DE50CEA8FCDQ38250247-9BFDEF47-23BF-4242-83C9-655EF7251D6AQ40145243-BE83CEE1-855C-48CA-A63D-61F4584ED2C3Q40614123-634D70D1-C028-42F7-A54B-449D87ECC4FDQ44111540-754E2A4C-07E1-472D-8126-A3B51622AC5BQ45401666-A0E257DA-8FB9-48C3-8814-3106F045E25EQ48187446-41803D8F-A5CD-49C8-AC8A-079730BC3F0AQ48348098-1DCF9A73-E249-4619-8094-3773528FF657Q53257147-FEB69817-03C4-4D9C-8ECE-A6BFBB0B84C2Q57212469-35B0ADD7-990D-4FAA-B85B-A3C09B4E19B2Q90571577-6F9252BE-CA07-4CC4-851C-D4F92AECCD52Q90602376-C77F3182-FA73-4BD2-B92F-ADD86E6B5999Q91330759-48C7709D-89E7-41BA-97E9-CC6A0F44952CQ91553330-76C05176-849B-4FDA-B234-948EE5527558
P50
description
researcher ORCID ID = 0000-0001-8089-2755
@en
wetenschapper
@nl
name
Seho Park
@ast
Seho Park
@en
Seho Park
@es
Seho Park
@nl
type
label
Seho Park
@ast
Seho Park
@en
Seho Park
@es
Seho Park
@nl
prefLabel
Seho Park
@ast
Seho Park
@en
Seho Park
@es
Seho Park
@nl
P31
P496
0000-0001-8089-2755